AlgoTx’s ATX01 Granted Fast Track Designation by FDA for Chemotherapy-Induced Neuropathic Pain

SURESNES, France–(BUSINESS WIRE)–AlgoTx announced today that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA), for the development of ATX01 in chemotherapy-induced neuropathic pain. “The FDA’s Fast Track designation of ATX01 reflects the critical unmet medical need of 60% of chemotherapy patients suffering from chemotherapy-induced neuropathic pain,” said Stéphane Thiroloix, … [Read more…]

Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development

Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services CAMBRIDGE, England–(BUSINESS WIRE)–Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Dr Benedetta Montagnini as Head of European Business Development. Driven by the uptake of its ion … [Read more…]

Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial

In Long-Term Exploratory Analysis, TAK-003 Prevented 84% of Hospitalizations and 61% of Symptomatic Dengue Illness Overall, with No Identified Important Safety Risks Results Through 4.5 Years Conclude the Evaluation of the Primary Two-Dose Series of TAK-003 TAK-003 is Currently Undergoing Regulatory Review for Potential Licensure in Both the European Union and Select Dengue-Endemic Countries OSAKA, … [Read more…]

Yourway Announces New Flagship European Depot in Dublin, Ireland

ALLENTOWN, Pa.–(BUSINESS WIRE)–Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, today announced construction of a new flagship European depot in Dublin, Ireland. The new GMP facility is being purpose-built to support Yourway’s clinical trials offering, including premium courier services, primary and secondary packaging, and temperature-controlled storage … [Read more…]

Poxel Announces New Solid Form Patent for PXL065 that Provides Additional Protection through 2041

Results of PXL065 Phase 2 (DESTINY-1) trial in NASH expected in Q3 2022 LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, announced today that the U.S. Patent and Trademark Office (PTO) has … [Read more…]

Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation in-person of a member of Sensorion’s senior management in the Gene Therapy Development and Manufacturing conference … [Read more…]

SINOVAC Polio Vaccine Prequalified by WHO

BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received the World Health Organization (WHO) prequalification for its Poliomyelitis Vaccine (Vero Cell, Inactivated Sabin strains) (“sIPV”) on June 2, 2022. The vaccine will be available for United Nations (UN) agencies to purchase … [Read more…]

IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

POTOMAC, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,351,152) to the Company titled “Method and Composition for Treating Seizure Disorders.” The patent is assigned to IGC and relates to compositions and methods for treating multiple types of seizure … [Read more…]

Free Webinar Will Share Insights for How Hospital and Healthcare Systems and Facilities Can Utilize Digital Tools

Swisslog Healthcare’s free webinar shares roadmap on how hospital and healthcare systems and facilities can transform digitally. BROOMFIELD, Colo.–(BUSINESS WIRE)–Swisslog Healthcare, a leading supplier in healthcare technology combining pharmacy and transport automation, is continuing its webinar series with “Maneuvering the Digital Transformation.” The webinar will be held on June 9, 2022, at 2 p.m. ET … [Read more…]

CWCI Notes Changes in the Mix of California Workers’ Comp Prescription Drugs and Payments

OAKLAND, Calif.–(BUSINESS WIRE)–New data from the California Workers’ Compensation Institute (CWCI) shows the types of drugs used to treat injured workers in California, and the distribution of payments for those medications, has shifted dramatically over the past decade, with opioids becoming far less prevalent and anti-inflammatory drugs (NSAIDs) accounting for an increasing share of the … [Read more…]